WuXi Biologics is producing a newly approved HIV med in the first Chinese biologics plant approved by the FDA

This week, the FDA approved Trogarzo, the first HIV therapy with a novel mechanism of action in more than 10 years and the first drug developed by Taiwan-based TaiMed Biologics. It also represents a first for WuXi Biologics, the Chinese company that will produce it at a biologics plant near Shanghai.Original Article